Contract Pharma Breaking News (Free subscription) | 18/11/2008
Affymetrix (Booth 631) has entered into a definitive agreement to acquire Panomics Inc. , a privately held Fremont, CA-based company that offers a suite of assay products for a wide variety of low to mid-plex genetic, protein and cellular analysis applications. The acquisition will strengthen Affymetrix’s position in high-growth validation and routine-testing market segments, according...
Fiercebiotech (Free subscription) | 12/11/2008
Affymetrix, a genetic data analysis equipment maker, announced today that it will purchase Fremont, CA-based Panomics for $73 million. Panomics has a suite of assay products for a wide variety of low to mid-plex genetic, protein and cellular analysis applications. Affymetrix says the buyout will boost its high-growth validation and routine-testing market segments. "As one company, we...
Red Orbit (Free subscription) | 11/11/2008
The East Bay Business Times (Free subscription) | 11/11/2008
Affymetrix Inc. has entered an agreement to buy Panomics Inc. of Fremont for $73 million in a cash deal, the company said Tuesday. (AFFX)
Fool.com (Free subscription) | 12/11/2008
Like Affymetrix's purchase of USB, the main benefit from purchasing Panomics will probably come in the form of cross-selling products. Affymetrix's products look at all of the genes in an organism, while Panomics' products are designed to look at specific genes. Affymetrix will also gain access to the research labs where Panomics has placed 5,600 instruments. As someone who's worked...
bizjournals (Free subscription) | 11/11/2008
Affymetrix Inc. said Tuesday it agreed to pay about $73 million in cash to acquire Panomics Inc., a privately held company that offers assay products for low to mid-plex genetic, protein and cellular analysis applications. (AFFX)
The Sacramento Business Journal (Free subscription) | 11/11/2008
Affymetrix Inc. said Tuesday it agreed to pay about $73 million in cash to acquire Panomics Inc., a privately held company that offers assay products for low to mid-plex genetic, protein and cellular analysis applications.
Business Wire (Free subscription) | 11/11/2008
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that it has entered into a definitive agreement to acquire Panomics Inc., a privately held Fremont,
Business Wire (Free subscription) | 11/11/2008
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) today announced the DMET™ Plus Premier Pack, the most comprehensive method for standardizing
The East Bay Business Times (Free subscription) | 23/10/2008
Affymetrix Inc. reported a $31.8 million loss for the September quarter. (AFFX)
Market Watch (Free subscription) | 23/10/2008
TEL AVIV (MarketWatch) -- Affymetrix Inc., the Santa Clara, Calif., developer of products based on genetic microarray technology, named Kevin M. King chief executive and a director, effective Jan. 1. As CEO, King, who is currently president, will succeed Stephen P.A. Fodor, Affymetrix's founder, the company said in a statement late on Wednesday. Fodor will take the post of executive...
Seeking Alpha China (Free subscription) | 25/10/2008
Affymetrix, Inc. (AFFX) Q3 2008 Earnings Call Transcript Complete Story »
Fool.com (Free subscription) | 24/10/2008
The good news is that Affymetrix has been in the business for a long time and therefore has a huge installed base. Its instruments are still being used, and sales of consumable products actually increased versus the year-ago quarter. That'll keep it afloat, but long term, Affymetrix has to increase sales of its machines if it's going to grow revenues.
The East Bay Business Times (Free subscription) | 23/10/2008
Affymetrix Inc. will transfer top executive responsibility at the company from CEO and Chairman Stephen Fodor to President Kevin King over the next two months. (AFFX)
Red Orbit (Free subscription) | 24/10/2008
Affymetrix Inc., (Nasdaq:AFFX) today reported its operating results for the third quarter of 2008. Total revenue for the quarter was $75.2 million, as compared to total revenue of $95.0 million in the third quarter of 2007.
